Dimethyl fumarate Mylan Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Teriflunomide Mylan Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multippel sklerose, relapsing-remitting - immunsuppressive - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - multippel sklerose, relapsing-remitting - immunosuppressants, selektiv immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Dimethyl fumarate Teva Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Sandoz 240 mg Norveġja - Norveġiż - Statens legemiddelverk

dimethyl fumarate sandoz 240 mg

sandoz a/s - dimetylfumarat - enterokapsel, hard - 240 mg

Dimethyl fumarate Sandoz 120 mg Norveġja - Norveġiż - Statens legemiddelverk

dimethyl fumarate sandoz 120 mg

sandoz a/s - dimetylfumarat - enterokapsel, hard - 120 mg

Dimethyl fumarate Accord Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Fampridine Sandoz 10 mg Norveġja - Norveġiż - Statens legemiddelverk

fampridine sandoz 10 mg

sandoz a/s - fampridin - depottablett - 10 mg